Health Care & Life Sciences » Medical Equipment & Supplies | Second Sight Medical Products Inc.

Second Sight Medical Products Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,564.90
3,397.90
8,950.00
3,985.00
7,964.00
6,896
Cost of Goods Sold (COGS) incl. D&A
5,629.30
3,558.10
4,302.00
9,349.00
7,753.00
4,888
Gross Income
4,064.40
160.30
4,648.00
5,364.00
211.00
2,008
SG&A Expense
14,107.70
21,092.40
23,704.00
27,119.00
31,456.00
36,833
EBIT
18,172.10
21,252.70
20,047.00
33,210.00
28,609.00
34,825
Unusual Expense
-
6,954.60
-
-
-
555
Non Operating Income/Expense
34.80
31.10
27.00
-
-
200
Interest Expense
5,013.60
7,034.10
-
-
-
-
Pretax Income
22,968.90
35,201.20
20,018.00
33,179.00
28,516.00
35,094
Consolidated Net Income
22,968.90
35,201.20
20,018.00
33,179.00
28,516.00
35,094
Net Income
22,968.90
35,201.20
20,018.00
33,179.00
28,516.00
35,094
Net Income After Extraordinaries
22,968.90
35,201.20
20,018.00
33,179.00
28,516.00
35,094
Net Income Available to Common
22,968.90
35,201.20
20,018.00
33,179.00
28,516.00
35,094
EPS (Basic)
0.66
1.41
0.56
0.84
0.53
0.53
Basic Shares Outstanding
34,625.60
25,052.80
35,637.00
39,554.00
54,152.00
66,378
EPS (Diluted)
0.66
1.41
0.56
0.84
0.53
0.53
Diluted Shares Outstanding
34,625.60
25,052.80
35,637.00
39,554.00
54,152.00
66,378
EBITDA
17,856.30
20,973.50
19,712.00
32,778.00
28,152.00
34,390
Other Operating Expense
-
-
991.00
727.00
2,636.00
-
Non-Operating Interest Income
7.50
9.10
2.00
31.00
93.00
86

About Second Sight Medical Products

View Profile
Address
12744 San Fernando Road
Sylmar California 91342
United States
Employees -
Website http://www.secondsight.com
Updated 07/08/2019
Second Sight Medical Products, Inc. develops, manufactures and markets prosthetic devices. Its product the Argus II System, treats outer retinal degenerations and employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The firm's system works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.